Christopher W. Ryan, MD

Oregon Health and Science University Knight Cancer Institute, Portland, OR, USA
Portland, Oregon, United States

Presentation(s):

• Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY

  Friday, November 18, 2022
  11:21 AM – 11:29 AM